ALIUXTA Trademark

Trademark Overview


On Tuesday, February 4, 2025, a trademark application was filed for ALIUXTA with the United States Patent and Trademark Office. The USPTO has given the ALIUXTA trademark a serial number of 99027910. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, June 17, 2025. This trademark is owned by Glaxo Group Limited. The ALIUXTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiopulmonary, genitourinary, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; excluding vaccines for the treatment of cancer and cardiovascular disorders; Anti-infectives
aliuxta

General Information


Serial Number99027910
Word MarkALIUXTA
Filing DateTuesday, February 4, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, June 17, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiopulmonary, genitourinary, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; excluding vaccines for the treatment of cancer and cardiovascular disorders; Anti-infectives

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 4, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG1 2NY
GB

Trademark Events


Event DateEvent Description
Tuesday, February 4, 2025APPLICATION FILING RECEIPT MAILED
Saturday, March 8, 2025ASSIGNED TO EXAMINER
Tuesday, February 4, 2025NEW APPLICATION ENTERED
Tuesday, February 4, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 13, 2025NON-FINAL ACTION E-MAILED
Tuesday, May 13, 2025NON-FINAL ACTION WRITTEN
Tuesday, June 17, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 17, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 17, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 13, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED